Skip to main content

ORIGINAL RESEARCH article

Front. Vet. Sci.
Sec. Comparative and Clinical Medicine
Volume 11 - 2024 | doi: 10.3389/fvets.2024.1471606

Serum symmetric dimethylarginine concentrations in enalapril-or telmisartan-treated dogs with proteinuric chronic kidney disease

Provisionally accepted

The final, formatted version of the article will be published soon.

    Renin-angiotensin-aldosterone system inhibition (RAASi) reduces intraglomerular pressure and is a standard therapy for dogs with proteinuric chronic kidney disease (CKD). RAASi can acutely decrease glomerular filtration rate (GFR); however, its effects on the marker of GFR serum symmetric dimethylarginine (SDMA) concentration in dogs have not been specifically evaluated. The objective of this study was to evaluate changes, relative to pretreatment values, in serum SDMA concentrations in dogs with proteinuric CKD receiving RAASi therapy. This retrospective study used banked samples from twenty-nine dogs with proteinuric CKD treated with enalapril (0.5 mg/kg PO q12h; n=16) or telmisartan (1 mg/kg PO q24h; n=13) alone (n=22) or in combination with amlodipine if severely hypertensive (n=7). Serum SDMA, creatinine, and urea nitrogen (SUN) concentrations were measured before and 7 and 30 days after starting RAASi. Percentage and absolute changes in these biomarkers were calculated for each dog and time point. A linear mixed model was used to test whether changes significantly differed from zero (α<0.05). Overall, mean±SEM Day 7 and 30 percentage change in SDMA were -4.8±3.6% and -3.2±3.4%, respectively; in creatinine were 7.4±3.3% and 3.0±3.1%, respectively; and in SUN were 22.1±6.8% and 16.7±6.2%, respectively. Mean changes varied according to whether all dogs, those on RAASi alone, or those co-treated with amlodipine were evaluated. In dogs receiving RAASi alone, at day 7, there were significant mean percentual increases in creatinine (9%; p=0.023) and SUN (23%; p=0.005), but SDMA was unchanged. In dogs co-treated with amlodipine, a significant absolute decrease in mean SDMA (-2.29 µg/dL; p=0.026) occurred at days 7 and 30, while mean creatinine was unchanged and mean SUN increased. In conclusion, proteinuric dogs receiving RAASi had low-magnitude changes in serum SDMA and creatinine, and moderate-magnitude changes in SUN concentrations. The direction of change in SDMA did not consistently match that of creatinine and SUN.

    Keywords: canine, Chronic Kidney Disease, Renal biomarkers, Azotemia, Urea nitrogen

    Received: 28 Jul 2024; Accepted: 22 Oct 2024.

    Copyright: © 2024 Nasr, Lourenço, Coleman and Bartges. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Amirah Nasr, University of Georgia, Athens, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.